The hearing loss treatment developer has filed to raise up to $100m, three months after a $105m round featuring Novartis, Partners HealthCare and Pivotal BioVenture Partners.

SoftBank, Allianz, XL Innovate and GV are in line for exits after the digital insurance provider filed for a $100m initial public offering.

TSE’s Mothers Market has approved an IPO for the engineer-oriented staffing services provider that would enable Crooz, InterWorks, MyNavi, Sega Sammy and Vector to exit.

Novartis bought $10m in shares as the fibrosis treatment developer floated at the top of its range in an expanded initial public offering.

The automotive e-commerce platform, which counts AutoNation among its investors, is set to raise up to $319m when it floats, at a valuation exceeding $1.9bn.

Celgene and BMS-backed cancer therapy developer Repare Therapeutics has filed to go public after raising more than $165m in equity financing.

The Legend Capital-backed industrial testing technology provider has filed to raise up to $98.8m when it floats on Shanghai’s Star Market.

The user interface engineering startup is set to list on TSE’s Mothers Market, handing exits to Blue Rose, Digital Garage, Finc, Mitsui Sumitomo Insurance and Salesforce.

The female-focused media services provider has listed in Japan, enabling Asahi Broadcasting, AsobiSystem, GMO, Gree, Hakuhodo DY, iStyle, MAK, NEC, Nexyz, Seraku, SoftBank and TBS to exit.

Existing investor Novartis has committed to a $10m private placement alongside the IPO, in which the fibrosis therapy developer, based on UCSF research, is set to raise up to $96m.